Uniphar has announced the appointment of Isaac Batley as Global Head of Medical and Scientific Communications.

In this pivotal role, Isaac will lead the growth of Uniphar’s medical communications capabilities, harnessing his 35 years of leadership experience working in healthcare communications within the pharmaceutical sector.

Isaac’s career includes serving as Chief Executive Officer at SCIRIS, where he scaled the medical communications division globally, and heading up the European Leadership Team at Cello Health before becoming Chairman of the communications agency.

Prior to this, Isaac built and sold his own medical communications agency and held a Director-level role at Quintiles, working specifically in clinical trials for the NHS.
Isaac spent the first part of his career working with AstraZeneca, Sanofi, and Pfizer. His experience and expertise position him to advance Uniphar’s medical communications, focusing on integrating scientific insights to benefit healthcare professionals, patients, and stakeholders.

Isaac will collaborate closely with key leaders across Uniphar, including Director of Medical Affairs, Maurice Leonard; Managing Director of Access, Dan Piggot; and Managing Director of Commercial, Karl Hamer, to ensure an integrated approach and cohesive medical communications strategy.

Commenting on his appointment, Isaac said: “Medical communications is the unifying thread that ties together the extensive service areas and capabilities that Uniphar has to offer. It touches every aspect of the organisation and presents an exciting opportunity to bring these capabilities together in a way that delivers impactful and meaningful results.”

Outrun Therapeutics has announced the appointment of Matthew Fyfe as its Chief Scientific Officer.

Matthew has over 25 years’ experience in drug discovery and development across multiple target classes, including oncology, immunology, neurology, ophthalmology and metabolic disease.

He joins from Storm Therapeutics, where he was Senior Vice President of Therapeutics, and has held senior leadership positions at various clinical-stage biotech companies, delivering clinical candidates that have reached phase 2 and beyond in several disease areas.

At Outrun, Matthew will be responsible for advancing the company’s therapeutics portfolio derived from its novel, proprietary X-E3L (Crosslinking E3 Labeller) technology platform, which accelerates the discovery of first-in-class small molecule protein-stabilising drugs targeting E3 ligases.

Dr Carolyn Porter, Chief Executive Officer at Outrun Therapeutics, said: “Matthew is a valuable addition to our leadership team, possessing a fantastic track record in the discovery and development of significant clinical-stage programmes across diverse therapeutic areas. He joins at a pivotal time for Outrun, and his breadth of experience will be key as we continue our progress towards the clinic.”

Matthew commented: “Outrun’s drug-hunting approach is among the most innovative in the space, offering a unique opportunity to target E3 ligases for protein stabilisation using its powerful X-E3L drug discovery platform, especially within the context of tumour suppression.”

Publicis Health has announced Annabelle Sandeman as its new Chief Growth Officer in the UK.

She will be responsible for driving the growth strategy of the Practice headquartered in London, incorporating the brands Digitas Health, Langland and Saatchi & Saatchi Wellness. She will report directly into Chief Executive Officer (CEO), Victoria Wright.

An industry titan with over 25 years’ experience, Annabelle brings an extensive track record and knowledge across the health sector, making her uniquely placed to drive growth and strategic development from the ground up.

She most recently held the role of Global Head of Commercial Strategy at Huntsworth, now Inizio. Since leaving Inizio, Annabelle has worked with Private Equity and agencies of all sizes and disciplines on their growth strategies across key clients and their needs.

Annabelle will continue to hold a position on the board of the Healthcare Communications Association, which unites agencies and global healthcare, pharmaceutical and biotech companies in advocating for the sector.

At Publicis Health she will have responsibility for setting the vision, the creation and execution of a long-term growth strategy as the agency navigates a period where health and wellness ever-more imperative to maintain, uphold and strengthen for all.

Annabelle said: “It is a great pleasure for me to join Publicis Health, which is home to world-renowned brands. Our clients are looking to transform and in a challenging market, they need the super skillset that Publicis Health offers.”